Go to deals
Healthcare | Private Equity

East West Eye Institute has been acquired by NVISION Eye Centers

East West Eye Institute (EWEI), one of the largest independent eyecare platforms in California, has sold a majority interest to Nvision Eye Centers, one of the larger providers of comprehensive eyecare, LASIK and cataract surgery services in the USA.

EWEI’s seven clinics, two state-of-the-art surgery centers, aesthetic center and clinical research division are strategically located across Los Angeles, with more than 35 practice partners, associates or affiliated community physicians providing more than 70,000 clinic visits per year.

Nvision, based in Aliso Viejo, California, is an innovative leader in ophthalmology and is backed by the Ontario Teachers’ Pension Plan. This transaction allows Nvision, with a combined 70 practice and ASC locations across five states (California, Nevada, Oregon, Washington and Arizona), to broaden its existing operations. Dr. Alex Liu will be promoted to the role of chief executive officer of the EWEI subsidiary to facilitate EWEI’s integration and to continue driving Nvision’s growth in the Los Angeles market.

Oaklins’ team in Los Angeles acted as the sell-side advisor in this transaction.

Parties
“We are thrilled to become part of the Nvision family. This combination is highly complementary given our combined focus on outstanding patient care, geographic footprint and service offerings which will enable Nvision and EWEI to better serve the community. Amid a challenging COVID-19 environment, the healthcare team in Los Angeles orchestrated a well-run deal process to help us secure an ideal strategic partner that will help EWEI grow for years to come.”

Dr. Fred Kurata

CEO, East West Eye Institute

Talk to the deal team

Adam Abramowitz

Managing Director
Los Angeles, United States
Oaklins Intrepid

Related deals

Valmiermuižas Alus has been acquired by Cēsu Alus
Private Equity | Food & Beverage

Valmiermuižas Alus has been acquired by Cēsu Alus

Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.

Learn more
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more
Capsol has been acquired by Angus Capital
Private Equity | Construction & Engineering Services

Capsol has been acquired by Angus Capital

Capsol has been acquired by Angus Capital as part of its strategy to build a leading construction services group alongside other portfolio companies. This partnership marks a new phase of growth for Capsol, providing the platform, resources and strategic support needed to accelerate its development and expand its market presence.

Learn more